Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characteristics and clinical outcomes of stereotactic radiosurgery for colorectal cancer brain metastases
    Meeting Abstract

    Gui, C.; Walch, H.; Mueller, K.; Eichholz, J.; Khatri, I.; Del Balzo, L.; Kemeny, N.; Imber, B.; Schultz, N.; Foote, M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • The genomic landscape of brain metastasis
    Meeting Abstract

    Skakodub, A.; Walch, H.; Kumar, R.; Eichholz, J.; Cooper, C.; Khatri, I.; Del Balzo, L.; Miao, E.; Gui, C.; Ma, J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
    Meeting Abstract

    Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Artificial intelligence-based assessment of HER2-low expression on breast cancer H&E digital whole slide images
    Meeting Abstract

    Retamero, J.; Oakley, J.; Reis-Filho, J.; Horton, M.; Klimstra, D.
    Journal of Pathology (2023)

    Fulltext@MSK | Save
  • International benchmark for total metabolic tumor volume assessment in baseline FDG PET/CT of lymphoma patients
    Meeting Abstract

    Boellaard, R.; Buvat, I.; Ceriani, L.; Cottereau, A. S.; Guerra, L.; Hicks, R.; Kanoun, S.; Kobe, C.; Loft, A.; Schoder, H.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Individualized dosing for high-dose targeted radiation of hematopoietic cells with Iomab-B (I131-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia (R/R AML): Safety and efficacy results from the pivotal phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • 89Zr-DFO-girentuximab PET/CT imaging can accurately detect clear cell renal cell carcinoma primary and secondary lesions in patients with renal masses at conventional imaging, results from ZIRCON phase 3 study
    Meeting Abstract

    Calais, J.; Shuch, B.; Pantuck, A.; Bernhard, J. C.; Morris, M.; Master, V.; Scott, A.; van Praet, C.; Bailly, C.; Aksoy, T.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Dose-escalation study of [225Ac]-FPI-1434 (FPI-1434) in patients (pts) with IGF-1R expressing advanced solid tumors: Preliminary pharmacology and dosimetry results
    Meeting Abstract

    Pandit-Taskar, N.; Wong, J.; Subbiah, V.; Chenard-Poirier, M.; Pryma, D.; Berlin, A.; Juergens, R.; Puzanov, I.; Jacene, H.; Schindler, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Administration and radiation safety of high-dose Iomab-B (I131-apamistamab) demonstrated in multiple clinical settings: Experience from the large multicenter phase 3 SIERRA trial for targeted conditioning of patients with relapsed/refractory AML
    Meeting Abstract

    Serencsits, B.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; McNamara, K.; Desai, A.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Comparison of MIRDfit and MIRDcalc tools with commercial software for dosimetry in radiopharmaceutical therapy
    Meeting Abstract

    Ramos, J. O.; Ramirez, E. M.; Carter, L.; Marquis, H.; Kesner, A.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save